Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II and IIIA nonbulky Hodgkin disease

被引：0
|
作者：
Drings, P
机构：
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2005年 / 181卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：747 / 748
页数：2
相关论文
共 20 条
  • [1] Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease
    Straus, DJ
    Portlock, CS
    Qin, J
    Myers, J
    Zelenetz, AD
    Moskowitz, C
    Noy, A
    Goy, A
    Yahalom, J
    BLOOD, 2004, 104 (12) : 3483 - 3489
  • [2] Results of a prospective randomized trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) alone vs. ABVD plus radiation therapy for early stage non bulky Hodgkin's disease.
    Straus, DJ
    Yahalom, J
    Zelenetz, AD
    Qin, J
    Myers, J
    Moskowitz, CH
    Noy, A
    Bertino, JR
    Portlock, CS
    BLOOD, 2001, 98 (11) : 769A - 769A
  • [3] Acute myeloid leukemia following therapy of Hodgkin's disease with radiotherapy and ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine)
    Lipton, JH
    Gospodarowicz, M
    Reingold, S
    HEMATOLOGICAL ONCOLOGY, 1996, 14 (01) : 29 - 31
  • [4] Three cycles of adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) or epirubicin, bleomycin, vinblastine, and methotrexate (EBVM) plus extended field radiation therapy in early and intermediate Hodgkin disease:: 10-year results of a randomized trial
    le Maignan, C
    Desablens, B
    Delwail, V
    Dib, M
    Berthou, C
    Vigier, M
    Ghandour, C
    Atmani, S
    Casassus, P
    Maisonneuve, H
    Le Mevel, A
    Traullé, C
    Bernard, M
    Brière, J
    Colonna, P
    Andrieu, JM
    BLOOD, 2004, 103 (01) : 58 - 66
  • [5] Benefits of BV-AVD (Brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine) versus ABVD (doxorubicin hydrochloride, bleomycin sulfate, vinblastine sulfate, dacarbazine) in patients with advanced-stage Hodgkin's lymphoma: an analysis of the ECHELON 1 trial by the GATLA group using the Delphi Method
    Pavlovsky, Astrid
    Altuve, Juan Ignacio Garcia
    Cerutti, Amalia
    Fiad, Lorena
    Kurgansky, Nicolas
    Warley, Fernando
    Aranguren, Florencia Negri
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 : S250 - S256
  • [6] Reduced Versus Full Doses of Irradiation After 3 Cycles of Combined Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in Early Stage Hodgkin Lymphomas Results of a Randomized Trial
    Arakelyan, Nina
    Jais, Jean-Philippe
    Delwail, Vincent
    Briere, Josette
    Moles-Moreau, Marie-Pierre
    Senecal, Delphine
    Berthou, Christian
    Desablens, Bernard
    Colonna, Pierre
    Andrieu, Jean-Marie
    CANCER, 2010, 116 (17) : 4054 - 4062
  • [7] Radiation therapy following complete clinical response after "ABVD" chemotherapy in Hodgkin's disease: is there a need - prospective trial from a single institution
    Laskar, S
    Muckaden, MA
    Saikia, TK
    Pai, SK
    Malde, R
    Ingle, P
    Sanghvi, V
    Bhalla, V
    Homkar, G
    Dedhia, R
    Shukla, A
    Dinshaw, KA
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 131 - 131
  • [8] Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVd (adriamycin, bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: a multicenter phase II study (JCOG 8905)
    Takenaka, T
    Mikuni, C
    Miura, A
    Sasaki, T
    Suzuki, H
    Hotta, T
    Hirano, M
    Fukuhara, S
    Sugiyama, H
    Nasu, K
    Dohi, H
    Kozuru, M
    Tomonaga, M
    Tajima, K
    Niimi, M
    Fukuda, H
    Mukai, K
    Shimoyama, M
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2000, 30 (03) : 146 - 152
  • [9] Four cycles of ABVD followed by involved field irradiation (IF-RT) is the treatment of choice for early-stage Hodgkin's disease (HD): 5-year results of a randomized trial
    Santoro, A
    Bonfante, V
    Viviani, S
    Zanini, M
    Devizzi, L
    Parra, HS
    DiRusso, A
    Soncini, F
    Villani, F
    Valagussa, P
    Bonadonna, G
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1185 - 1185
  • [10] Stanford V (SV) versus ABVD for adult patients with advanced Hodgkin's disease (HD): Preliminary results of a randomized phase II trial from the BNLI.
    Sweetenham, J
    Smith, P
    MacMillan, A
    Cunningham, D
    Hoskin, P
    Horwich, A
    Linch, D
    BLOOD, 2000, 96 (11) : 249B - 249B
12